BELODERM

This brand name is authorized in Albania, Croatia, Poland

Active ingredients

The drug BELODERM contains one active pharmaceutical ingredient (API):

1 Betamethasone
UNII 826Y60901U - BETAMETHASONE DIPROPIONATE

Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties.

Read about Betamethasone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
D07CC01 Betamethasone and antibiotics D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07C Corticosteroids, combinations with antibiotics → D07CC Corticosteroids, potent, combinations with antibiotics
Discover more medicines within D07CC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AL Fondi i Sigurimit të Detyrueshëm të Kujdesit Shëndetësor Identifier(s): 95/245, 95/245a
Country: HR Agencija za lijekove i medicinske proizvode Identifier(s): HR-H-293491453, HR-H-357312417, HR-H-998808042
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100135234, 100135240

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.